Artal Group’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,500,000
| Closed | -$24.3M | – | 159 |
|
|
2021
Q2 | $24.3M | Hold |
2,500,000
| – | – | 0.49% | 38 |
|
|
2021
Q1 | $26.9M | Buy |
2,500,000
+400,000
| +19% | +$4.3M | 0.47% | 40 |
|
|
2020
Q4 | $30.9M | Buy |
2,100,000
+600,000
| +40% | +$8.83M | 0.66% | 38 |
|
|
2020
Q3 | $21.3M | Buy |
1,500,000
+547,000
| +57% | +$7.77M | 0.52% | 33 |
|
|
2020
Q2 | $7.71M | Sell |
953,000
-47,000
| -5% | -$380K | 0.22% | 69 |
|
|
2020
Q1 | $4.04M | Buy |
+1,000,000
| New | +$4.04M | 0.17% | 71 |
|
|
2019
Q2 | – | Sell |
-150,000
| Closed | -$99K | – | 116 |
|
|
2019
Q1 | $99K | Hold |
150,000
| – | – | ﹤0.01% | 89 |
|
|
2018
Q4 | $257K | Hold |
150,000
| – | – | 0.01% | 78 |
|
|
2018
Q3 | $870K | Hold |
150,000
| – | – | 0.02% | 80 |
|
|
2018
Q2 | $900K | Hold |
150,000
| – | – | 0.02% | 77 |
|
|
2018
Q1 | $1.08M | Hold |
150,000
| – | – | 0.01% | 77 |
|
|
2017
Q4 | $1.09M | Buy |
+150,000
| New | +$1.09M | 0.02% | 74 |
|